Home Cart 0 Sign in  
X

[ CAS No. 34784-07-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 34784-07-1
Chemical Structure| 34784-07-1
Chemical Structure| 34784-07-1
Structure of 34784-07-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 34784-07-1 ]

Related Doc. of [ 34784-07-1 ]

Alternatived Products of [ 34784-07-1 ]

Product Details of [ 34784-07-1 ]

CAS No. :34784-07-1 MDL No. :MFCD07644622
Formula : C9H6ClN Boiling Point : -
Linear Structure Formula :- InChI Key :OXAMVYYZTULFIB-UHFFFAOYSA-N
M.W : 163.60 Pubchem ID :640954
Synonyms :

Calculated chemistry of [ 34784-07-1 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 46.75
TPSA : 12.89 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.36 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.91
Log Po/w (XLOGP3) : 2.73
Log Po/w (WLOGP) : 2.89
Log Po/w (MLOGP) : 2.15
Log Po/w (SILICOS-IT) : 3.13
Consensus Log Po/w : 2.56

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.25
Solubility : 0.0926 mg/ml ; 0.000566 mol/l
Class : Soluble
Log S (Ali) : -2.65
Solubility : 0.362 mg/ml ; 0.00221 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.31
Solubility : 0.00807 mg/ml ; 0.0000493 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.22

Safety of [ 34784-07-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 34784-07-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 34784-07-1 ]
  • Downstream synthetic route of [ 34784-07-1 ]

[ 34784-07-1 ] Synthesis Path-Upstream   1~23

  • 1
  • [ 587-04-2 ]
  • [ 22483-09-6 ]
  • [ 34784-06-0 ]
  • [ 34784-07-1 ]
Reference: [1] Patent: US2007/254879, 2007, A1, . Location in patent: Page/Page column 29; 30
  • 2
  • [ 34784-07-1 ]
  • [ 3482-14-2 ]
YieldReaction ConditionsOperation in experiment
72% With copper acetylacetonate; lithium hydroxide monohydrate; 1,3-bis(4-hydroxy-2,6-dimethylphenyl)urea In water; dimethyl sulfoxide at 130℃; for 24 h; Inert atmosphere n 49. lmL dimethyl sulfoxide and 12.3 mL Water was added 10 g of a mixture of 61.35 mmol 8-chloroisoquinoline, 0.8], 3.07 mmol of copper acetylacetonate, 2.71 g, 64.42 mmol-hydrated hydroxide and 0.92 g, 3.07 mmol L-1,3-bis (4-hydroxy-2,6-dimethylphenyl) urea. The reaction solution was stirred at 130 ° C for 24 hours under nitrogen. After the reaction solution to be stirred was cooled, The solution was acidified with 2 mol / L HC1 to ρH- = 5, The mixture was extracted with ethyl acetate, The extracted organic phase was washed with saturated brine, Dried over anhydrous sodium sulfate and dried, The crude product was separated by column chromatography to give 8-hydroxyisoquinoline 6.41 g, the total yield was 72percent.
Reference: [1] Patent: CN106966977, 2017, A, . Location in patent: Paragraph 0016; 0018-0019
  • 3
  • [ 956003-79-5 ]
  • [ 34784-07-1 ]
YieldReaction ConditionsOperation in experiment
44% With sodium tetrahydroborate; palladium 10% on activated carbon In 2-methyltetrahydrofuran; methanol at 25℃; for 1.16667 h; Inert atmosphere A one-necked glass flask was charged with 12 (1.20 g, 4.95 mmol, 1.0equiv), 2-methyltetrahydrofuran (10 mL), and MeOH (10 mL), andthen N 2 gas was bubbled through the mixture. Under an inert atmo-sphere, 10percent Pd/C (530 mg, 0.5 mmol, 0.1 equiv) was added followed by careful addition of NaBH 4 (206 mg, 5.45 mmol, 1.1 equiv). The flaskwas closed by a gas bubbler filled with silicon oil. The mixture wasstirred for 70 min at 25 °C (longer reaction times resulted in an exten-sive formation of over-reduced products such as 1,2,3,4-tetrahy-droisoquinoline and 8-chloro-1,2,3,4-tetrahydroisoquinoline), andthen quenched with glacial AcOH (500 μL, 8.74 mmol, 1.75 equiv).The mixture was then stirred for another 10 min, followed by filtra-tion through Celite. The cake was washed with MeOH and CH 2 Cl 2 . Thefiltrate was evaporated and the residue was purified by flash chroma-tography (silica gel, hexane–EtOAc, 93:7), which afforded off-whitecrystals.Yield: 360 mg (44percent); mp 50–55 °C.IR (ATR): 1620, 1553, 1429, 1379, 1300, 1204, 1038, 970, 827, 748,686, 634, 534 cm –1 .1 H NMR (400 MHz, CDCl 3 ): δ = 9.66 (s, 1 H), 8.60 (d, J = 5.7 Hz, 1 H),7.73 (d, J = 7.9 Hz, 1 H), 7.69–7.56 (m, 3 H).13 C NMR (100 MHz, CDCl 3 ): δ = 149.4, 143.8, 137.1, 132.5, 130.3,127.5, 125.6, 125.7, 120.1.
Reference: [1] Synthesis (Germany), 2018, vol. 50, # 11, p. 2181 - 2190
  • 4
  • [ 23687-27-6 ]
  • [ 34784-07-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2005, vol. 48, # 15, p. 4972 - 4982
[2] Patent: WO2007/42906, 2007, A1, . Location in patent: Page/Page column 37
  • 5
  • [ 587-04-2 ]
  • [ 22483-09-6 ]
  • [ 34784-06-0 ]
  • [ 34784-07-1 ]
Reference: [1] Patent: US2007/254879, 2007, A1, . Location in patent: Page/Page column 29; 30
  • 6
  • [ 956003-79-5 ]
  • [ 34784-07-1 ]
  • [ 91-21-4 ]
  • [ 75416-50-1 ]
Reference: [1] Synthesis (Germany), 2018, vol. 50, # 11, p. 2181 - 2190
  • 7
  • [ 34784-04-8 ]
  • [ 34784-07-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2005, vol. 48, # 15, p. 4972 - 4982
[2] Synthesis (Germany), 2018, vol. 50, # 11, p. 2181 - 2190
  • 8
  • [ 63927-23-1 ]
  • [ 34784-07-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2005, vol. 48, # 15, p. 4972 - 4982
  • 9
  • [ 62882-12-6 ]
  • [ 34784-07-1 ]
Reference: [1] Journal of Medicinal Chemistry, 1980, vol. 23, # 5, p. 506 - 511
  • 10
  • [ 119-65-3 ]
  • [ 34784-07-1 ]
Reference: [1] Synthesis (Germany), 2018, vol. 50, # 11, p. 2181 - 2190
  • 11
  • [ 119-65-3 ]
  • [ 34784-07-1 ]
  • [ 91-21-4 ]
  • [ 75416-50-1 ]
Reference: [1] Synthesis (Germany), 2018, vol. 50, # 11, p. 2181 - 2190
  • 12
  • [ 34784-04-8 ]
  • [ 34784-07-1 ]
  • [ 91-21-4 ]
  • [ 75416-50-1 ]
Reference: [1] Synthesis (Germany), 2018, vol. 50, # 11, p. 2181 - 2190
  • 13
  • [ 855645-64-6 ]
  • [ 34784-07-1 ]
Reference: [1] Canadian Journal of Research, Section B: Chemical Sciences, 1949, vol. 27, p. 161,166
  • 14
  • [ 607-35-2 ]
  • [ 34784-07-1 ]
Reference: [1] Yakugaku Zasshi, 1953, vol. 73, p. 666[2] Chem.Abstr., 1954, p. 7014
  • 15
  • [ 855736-55-9 ]
  • [ 34784-07-1 ]
Reference: [1] Canadian Journal of Research, Section B: Chemical Sciences, 1949, vol. 27, p. 161,166
  • 16
  • [ 760118-44-3 ]
  • [ 34784-07-1 ]
Reference: [1] Canadian Journal of Research, Section B: Chemical Sciences, 1949, vol. 27, p. 161,166
  • 17
  • [ 23707-37-1 ]
  • [ 34784-07-1 ]
Reference: [1] Canadian Journal of Research, Section B: Chemical Sciences, 1949, vol. 27, p. 161,166
  • 18
  • [ 89-98-5 ]
  • [ 645-36-3 ]
  • [ 34784-07-1 ]
Reference: [1] Monatshefte fuer Chemie, 1897, vol. 18, p. 5[2] Monatshefte fuer Chemie, 1894, vol. 15, p. 304
  • 19
  • [ 34784-07-1 ]
  • [ 75416-50-1 ]
Reference: [1] Journal of Medicinal Chemistry, 1980, vol. 23, # 5, p. 506 - 511
  • 20
  • [ 956003-79-5 ]
  • [ 34784-07-1 ]
  • [ 91-21-4 ]
  • [ 75416-50-1 ]
Reference: [1] Synthesis (Germany), 2018, vol. 50, # 11, p. 2181 - 2190
  • 21
  • [ 119-65-3 ]
  • [ 34784-07-1 ]
  • [ 91-21-4 ]
  • [ 75416-50-1 ]
Reference: [1] Synthesis (Germany), 2018, vol. 50, # 11, p. 2181 - 2190
  • 22
  • [ 34784-04-8 ]
  • [ 34784-07-1 ]
  • [ 91-21-4 ]
  • [ 75416-50-1 ]
Reference: [1] Synthesis (Germany), 2018, vol. 50, # 11, p. 2181 - 2190
  • 23
  • [ 34784-07-1 ]
  • [ 848841-64-5 ]
YieldReaction ConditionsOperation in experiment
72%
Stage #1: With 3-chloro-benzenecarboperoxoic acid In dichloromethane for 3 h;
Stage #2: With phosphorus pentachloride In toluene for 3 h; Heating / reflux
20a) 1, 8-DICHLORO-ISOQUINOLINE To a solution of 8-chloro-isoquinoline (J. Org. Chem. 1977,42 (19), 3208-9.) (11 G, 54 MMOL) in CH2CI2 (200 mL) is added MCPBA (25 g, 112 MMOL) in several portions. After stirring for 3 hours, ether (400 mL) is added, followed by addition of hexanes (1 L). Solution stirred overnight and conc in vacuo, ether (200 mL) and hexanes (400 mL) is added, stirred overnight. The ppt is filtered, air dried and mixed with 20 g of POS and toluene (150 mL). The solution is heated to reflux for 3 h, neutralized with NAHCO3. Extracted the solution with CH2CI2. Organic layer then dried with sodium sulfate and conc in vacuo, yield 8 g (72percent) of 1, 8-Dichloro-isoquinoline. MS: 198
Reference: [1] Patent: WO2005/28444, 2005, A1, . Location in patent: Page/Page column 67-68
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 34784-07-1 ]

Chlorides

Chemical Structure| 5430-45-5

[ 5430-45-5 ]

5-Chloroisoquinoline

Similarity: 0.96

Chemical Structure| 34784-06-0

[ 34784-06-0 ]

7-Chloroisoquinoline

Similarity: 0.90

Chemical Structure| 62882-02-4

[ 62882-02-4 ]

6-Chloroisoquinoline

Similarity: 0.90

Chemical Structure| 848841-64-5

[ 848841-64-5 ]

1,8-Dichloroisoquinoline

Similarity: 0.86

Chemical Structure| 934554-41-3

[ 934554-41-3 ]

8-Chloroisoquinolin-5-amine

Similarity: 0.86

Related Parent Nucleus of
[ 34784-07-1 ]

Isoquinolines

Chemical Structure| 5430-45-5

[ 5430-45-5 ]

5-Chloroisoquinoline

Similarity: 0.96

Chemical Structure| 34784-06-0

[ 34784-06-0 ]

7-Chloroisoquinoline

Similarity: 0.90

Chemical Structure| 62882-02-4

[ 62882-02-4 ]

6-Chloroisoquinoline

Similarity: 0.90

Chemical Structure| 848841-64-5

[ 848841-64-5 ]

1,8-Dichloroisoquinoline

Similarity: 0.86

Chemical Structure| 934554-41-3

[ 934554-41-3 ]

8-Chloroisoquinolin-5-amine

Similarity: 0.86